Nav: Home

BU study probes soda company sponsorship of health groups

October 10, 2016

The nation's two largest soda companies sponsored at least 96 national health organizations from 2011 to 2015, dampening the health groups' support of legislation to reduce soda consumption and impeding efforts to combat the obesity epidemic, Boston University researchers say in a new study.

In addition, in the same five-year period, the Coca-Cola Company and PepsiCo lobbied against at least 28 public health bills intended to reduce soda consumption or improve nutrition, according to the study in the American Journal of Preventive Medicine.

The companies "used relationships with health organizations to develop positive associations for their brands," said lead author Daniel Aaron, a medical student at the BU School of Medicine who co-wrote the study with Michael Siegel, MD, professor of community health sciences at the School of Public Health.

"The soda companies can neutralize potential legislative opposition by invoking reciprocity and financial dependence from national health organizations," he said. "Rather than supporting public health, organizations may become unwitting partners in a corporate marketing strategy that undermines public health."

Aaron and Siegel researched sponsorships and lobbying efforts by the two soda companies to come up with a list of 96 national health organizations that accepted money from the companies. Twelve organizations accepted money from both companies; one accepted money from just PepsiCo; and 83 accepted money from only Coca-Cola. The authors note that the count could be skewed because Coca-Cola publishes a list of its recipient organizations, while PepsiCo doesn't.

The sponsorship totals include two diabetes organizations -- the American Diabetes Association and the Juvenile Diabetes Research Foundation - a finding that the authors called "surprising, given the established link between diabetes and soda consumption."

The study also identifies 28 bills or proposed regulations, including soda taxes and restrictions on advertising, that were opposed by the soda companies or their lobbying groups. Siegel and Aaron said these efforts demonstrate the companies' "primary interest of improving profit, at the expense of public health."

Between 2011 and 2014, the Coca-Cola Company spent more than $6 million annually, on average, on lobbying, while PepsiCo spent more than $3 million a year, and the American Beverage Association spent more than $1 million a year, according to the study.

Aaron and Siegel compared the ties between soda companies and health groups to corporate sponsorships of tobacco and alcohol companies.

"Previous studies of alcohol company sponsorship and tobacco sponsorship suggest that corporate philanthropy is a marketing tool that can be used to silence health organizations that might otherwise lobby and support public health measures against these industries," Siegel said. For example, Save the Children, a group that supported soda taxes, dropped the effort in 2010 after receiving more than $5 million from the Coca-Cola Company and PepsiCo in 2009, the study says.

The study recommends that health organizations reject sponsorship offers from soda companies and find alternative sources of funding. It notes that Academy of Nutrition and Dietetics, the American Academy of Pediatrics and other organizations did not renew contracts with Coca-Cola at the end of 2015.

The U.S. has one of the highest rates of obesity in the world, with soda consumption identified as one of the factors. On average, Americans consumed 46 gallons of soda in 2009, giving the U.S. one of the highest rates of per capita soda consumption of any country.

A recent report estimated that soda consumption caused one-fifth of weight gain in the U.S. between 1977 and 2007.
-end-


Boston University Medical Center

Related Diabetes Articles:

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
More Diabetes News and Diabetes Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.